Last reviewed · How we verify
NCT03086811: MI-FI
"Improved Mother Infant Feeding Interaction (MI-FI) at 12 Months With Very Early Parent Training"
NA trial testing Mother Infant Feeding Interaction very early training in Picky Eaters, Feeding Interaction, Good Enough Parenting, Family Meals, Emotional Eating Prevention in 166 participants. Completed in 21 July 2013.
21 July 2013
Quick facts
| Lead sponsor | Rambam Health Care Campus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 166 |
| Start date | 25 October 2011 |
| Primary completion | 21 July 2013 |
| Estimated completion | 21 July 2013 |
Drugs / interventions tested
- Mother Infant Feeding Interaction very early training
Conditions studied
- Picky Eaters, Feeding Interaction, Good Enough Parenting, Family Meals, Emotional Eating Prevention — all drugs for Picky Eaters, Feeding Interaction, Good Enough Parenting, Family Meals, Emotional Eating Prevention →
Sponsor
Rambam Health Care Campus — full company profile →
Who can join
Adults 23 to 35, female only, with Picky Eaters, Feeding Interaction, Good Enough Parenting, Family Meals, Emotional Eating Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rise in childhood obesity and poor eating habits and eating problems is apparent over the last decades. Parents are at lose what the correct way to tackle these problems may be. This study examined whether professional behavioral and nutritional training of first time mothers improves feeding relationship and infants eating habits at 12 months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03086811
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Rambam Health Care Campus trials
Trials by the same sponsor.
- NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
- NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
- NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
- NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
- NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03086811 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
- Last refreshed: 7 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03086811.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing